Literature DB >> 7806368

Persistence of local cytokine production in shigellosis in acute and convalescent stages.

R Raqib1, A A Lindberg, B Wretlind, P K Bardhan, U Andersson, J Andersson.   

Abstract

Shigella infection is accompanied by an intestinal activation of epithelial cells, T cells, and macrophages within the inflamed colonic mucosa. A prospective study was carried out to elucidate the cytokine pattern in Shigella infection linked to development of immunity and eradication of bacteria from the local site and also to correlate the cytokine profile with histological severity. An indirect immunohistochemical technique was used to determine the production and localization of various cytokines at the single-cell level in cryopreserved rectal biopsies from 24 patients with either Shigella dysenteriae type 1 (n = 18) or Shigella flexneri (n = 6) infection. The histopathological profile included presence of chronic inflammatory cells with or without neutrophils and microulcers in the lamina propria, crypt distortion, branching, and less frequently crypt abscesses. Patients had significantly higher (P < 0.005) numbers of cytokine producing cells for all of the cytokines studied, interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-1ra, tumor necrosis factor alpha (TNF-alpha), IL-6, IL-8, IL-4, IL-10, gamma interferon, TNF-beta, and transforming growth factor beta 1-3, in the biopsies than the healthy controls (n = 13). The cytokine production profile during the study period was dominated by IL-1 beta, transforming growth factor beta 1-3, IL-4, and IL-10. Significantly increased frequencies of cytokine-producing cells (P < 0.05) were observed for IL-1, IL-6, gamma interferon, and TNF-alpha in biopsies with severe inflammation in comparison with those with mild inflammation. During the acute stage of the disease, 20 of 24 patients exhibited acute inflammation in the rectal biopsies and the cellular infiltration was still extensive 30 days after the onset of diarrhea, although the disease was clinically resolved. In accordance with the histological findings, cytokine production was also upregulated during the convalescent phase; there was no significant difference (P > 0.05) in the incidence of cytokine-producing cells between acute (2 to 8 days after the onset of diarrhea) and convalescent (30 days after onset) stages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806368      PMCID: PMC172990          DOI: 10.1128/iai.63.1.289-296.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Enhanced mucosal cytokine production in inflammatory bowel disease.

Authors:  W E Pullman; S Elsbury; M Kobayashi; A J Hapel; W F Doe
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

2.  Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.

Authors:  V L Tesh; J E Samuel; L P Perera; J B Sharefkin; A D O'Brien
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

3.  Monoclonal antibody two-site ELISA for human IFN-gamma. Adaptation for determinations in human serum or plasma.

Authors:  G Andersson; H P Ekre; G Alm; P Perlmann
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

4.  Dysentery, not watery diarrhoea, is associated with stunting in Bangladeshi children.

Authors:  F J Henry; N Alam; K M Aziz; M M Rahaman
Journal:  Hum Nutr Clin Nutr       Date:  1987-07

5.  Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes.

Authors:  A Olofsson; K Miyazono; T Kanzaki; P Colosetti; U Engström; C H Heldin
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

6.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Colonic mucosal interleukin-6 in inflammatory bowel disease.

Authors:  K Mitsuyama; E Sasaki; A Toyonaga; H Ikeda; O Tsuruta; A Irie; N Arima; T Oriishi; K Harada; K Fujisaki
Journal:  Digestion       Date:  1991       Impact factor: 3.216

8.  Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties.

Authors:  G Luo; D W Niesel; R A Shaban; E A Grimm; G R Klimpel
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

9.  Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.

Authors:  H Z Movat; C E Burrowes; M I Cybulsky; C A Dinarello
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

10.  Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

Authors:  J Brynskov; N Tvede; C B Andersen; M Vilien
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more
  52 in total

Review 1.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

2.  Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.

Authors:  Chien-Chang Chen; Chee-Jen Chang; Tzou-Yien Lin; Ming-Wei Lai; Hsun-Chin Chao; Man-Shan Kong
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 3.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

4.  Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.

Authors:  A K Ulfgren; S Lindblad; L Klareskog; J Andersson; U Andersson
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

Review 5.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

6.  Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.

Authors:  R Raqib; A Ljungdahl; A A Lindberg; U Andersson; J Andersson
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Pradip Maiti; Joydeep Mukherjee; Arpita Panda; Dhira Rani Saha
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

8.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

9.  Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis.

Authors:  Kopperuncholan Namachivayam; Cynthia L Blanco; Krishnan MohanKumar; Ramasamy Jagadeeswaran; Margarita Vasquez; Lisa McGill-Vargas; Steven A Garzon; Sunil K Jain; Ravinder K Gill; Nancy E Freitag; Jörn-Hendrik Weitkamp; Steven R Seidner; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-15       Impact factor: 4.052

10.  Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.

Authors:  Dong-Oh Moon; Se-Rim Choi; Chang-Min Lee; Gi-Young Kim; Hee-Jeong Lee; Yeong-Min Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.